Journal of Substance Abuse Treatment
Volume 39, Issue 2 , Pages 87-95 , September 2010

Priorities for policy research on treatments for alcohol and drug use disorders

  • Dennis McCarty, Ph.D.

      Affiliations

    • Oregon Health & Science University, Portland, OR 97239, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 503 494 1177; fax: +1 503 494 4981.
    • ,
  • K. John McConnell, Ph.D.

      Affiliations

    • Oregon Health & Science University, Portland, OR 97239, USA
    • ,
  • Laura A. Schmidt, Ph.D., M.S.W., M.P.H.

      Affiliations

    • University of California, San Francisco, San Francisco, CA 94118, USA

Received 22 December 2009 ,Revised 17 April 2010 ,Accepted 3 May 2010.

References 

  1. Aday LA. Who are the vulnerable. At Risk in America. San Francisco: Jossey-Bass Publishers; 1993;
  2. Amass L, Ling W, Freese TE, Reiber C, Annon JJ, Cohen AJ, et al. Bringing buprenorphine–naloxone detoxification to community treatment programs: The NIDA Clinical Trial Network field experience. The American Journal on Addictions. 2004;13:S42–S66
  3. Berenson RA, Hammons T, Gans DN, Zuckerman S, Merrell K, Underwood WS, et al. A house is not a home: Keeping patients at the center of practice redesign. Health Affairs. 2008;27:1219–1230
  4. Bradley EH, Herrin J, Elbel B, McNamara RL, Magid DJ, Nallamothu BK, et al. Hospital quality for acute myocardial infarction: Correlation among process measures and relationship with short-term quality. Journal of American Medical Association. 2006;296:72–78
  5. Burnam MA, Bing EG, et al. Use of mental health and substance abuse treatment services among adults with HIV in the United States. (Statistical Data Included). Archives of General Psychiatry. 2001;58(8):729
  6. Capoccia VA, Cotter F, Gustafson DH, Cassidy E, Ford J, Madden L, et al. Making “stone soup”: How process improvement is changing the addiction treatment field. Joint Commission Journal on Quality and Patient Safety. 2007;33:95–103
  7. Carroll KM, Ball SA, Nich C, Martino S, Frankforter TL, Farentinos C, et al. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study. Drug and Alcohol Dependence. 2006;81:301–312
  8. Corredoira RA, Kimberly JR. Industry evolution through consolidation: Implications for addiction treatment. Journal of Substance Abuse Treatment. 2008;31:255–265
  9. D'Aunno T. The role of organization and management in substance abuse treatment: Review and roadmap. Journal of Substance Abuse Treatment. 2006;31:221–233
  10. In:  Edmunds M,  Frank R, et al. editor. Managing managed care: Quality improvement in behavioral health (summary). Washington, DC: National Academy of Sciences, Institute of Medicine; 1997;
  11. Ettner SL, Huang D, Evans E, Ash DR, Hardy M, Jourabchi M, et al. Benefit–Cost in the California Treatment Outcome Project: Does substance abuse treatment “pay for itself”?. Health Services Research. 2006;41:192–213
  12. Fixsen DL, Naoom SF, Blase KA, Friedman RM, Wallace F. Implementation research: A synthesis of the literature. Tampa, FL: University of South Florida, Louis de la Parte Florida Mental Health Institute, The National Implementation Research Network; 2005;
  13. Garnick D, Horgan C, Lee MT, Panas L, Ritter GA, Davis SA. Are Washington Circle performance measures associated with decreased criminal activity following treatment. Journal of Substance Abuse Treatment. 2007;341–352
  14. Garnick DW, Lee MT, Chalk M, Gastfriend DR, Horgan CM, McCorry F, et al. Establishing the feasibility of performance measures for alcohol and other drugs. Journal of Substance Abuse Treatment. 2002;23:375–385
  15. Treating drug problems: Volume 1. In:  Gerstein DR,  Harwood HJ editor. A study of the evolution, effectiveness, and financing of public and private drug treatment systems. Washington DC: National Academy Press; 1990;
  16. Harris A, Humphreys KN, Finney JW. Veterans Affairs facility performance on Washington Circle indicators and casemix-adjusted effectiveness. Journal of Substance Abuse Treatment. 2007;333–339
  17. Hoffman K, Ford JH, Choi D, Gustafson D, McCarty D. Replication and sustainability of improved access and retention within the Network for the Improvement of Addiction Treatment. Drug and Alcohol Dependence. 2008;98:63–69
  18. Institute of Medicine . Managing managed care: Quality improvement in behavioral health. Washington, DC: National Academy Press; 1997;
  19. Institute of Medicine . Crossing the quality chasm: A new health system for the 21st century. Washington, DC: National Academy Press; 2001;
  20. Institute of Medicine . Improving the quality of health care for mental and substance-use disorders: Quality chasm series. Washington, DC: National Academy Press; 2006;
  21. Kimberly JR, McLellan AT. The business of addiction treatment: A research agenda. Journal of Substance Abuse Treatment. 2006;31:213–219
  22. Knott AM, Corredoira R, Kimberly J. Improving consistency and quality of service delivery: Implications for the addiction treatment field. Journal of Substance Abuse Treatment. 2008;35t:99–108
  23. Knudsen HK, Johnson JA, Roman PM. Retaining counseling staff at substance abuse treatment centers: Effects of management practices. Journal of Substance Abuse Treatment. 2003;24:129–135
  24. Ling W, Amass L, Shoptow M, Annon JJ, Hillhouse M, Babcock D, et al. A multi-center randomized trial of buprenorphine–naloxone versus clonidine for opioid detoxification: Findings from the National Institute on Drug Abuse's Clinical Trial Network. Addiction. 2005;100:1090–1100
  25. Mark TL, Levit KR, Coffey RM, McKusick D, Harwood HJ, King E, et al. National Expenditures for Mental Health Services and Substance Abuse Treatment: 1993–2003. Rockville, MD: Aubstance Abuse and Mental Health Services Administration; 2007;(SAMHSA Publication No. SMA 07-4227 ed.)
  26. McCarty D, Capoccia VA, Gustafson D. Quality improvement for addiction treatment. In principles of addiction medicine. New York: Lippencott, Williams & Wilkens; 2009;
  27. McCarty D, Gustafson DH, Wisdom JP, Ford J, Choi D, Molfenter T, et al. The Network for the Improvement of Addiction Treatment (NIATx): Enhancing access and retention. Drug and Alcohol Dependence. 2007;88:138–145
  28. McCorry F, Garnick DW, Bartlett J, Cotter F, Chalk M. Developing performance measures for alcohol and other drug services in managed care plans. Joint Commission Journal on Quality Improvement. 2000;26:633–643
  29. McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP. The effects of psychosocial services in substance abuse treatment. Journal of American Medical Association. 1993;269:1953–1959
  30. McLellan AT, Carise D, Kleber HD. Can the national addiction treatment infrastructure support the public's demand for quality care?. Journal of Substance Abuse Treatment. 2003;25:117–121
  31. McLellan AT, Chalk M, Bartlett J. Outcomes, performance and quality—Whats the difference?. Journal of Substance Abuse Treatment. 2007;32:331–340
  32. McLellan AT, Lewis DC, O'brien CP, Kleber HD. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association. 2000;284:1689–1695
  33. McLellan TA, Woody GE, et al. Evaluating the effectiveness of addiction treatments: Reasonable expectations, appropriate comparisons. Milbank Quarterly. 1996;74:51–85
  34. Mechanic D, McAlpine D. Mission unfulfilled: Potholes on the road to mental health parity. Health Affairs. 1999;18:7–21
  35. Miller RH. Health care organizational change: Implications for access to care and its measurement. In: Health policy: Crisis and reform in the U.S. health care delivery system. Sudbury, MA: Jones and Bartlett Publishers; 2001;p. 326–340
  36. Nageotte C. Prenatal providers' and patients agreement on alcohol, tobacco, and other drug (ATOD) use counseling: Comparison of public health and managed care settings. Psychiatry in Medicine. 1997;27:343–344
  37. National Quality Forum . National voluntary consensus standards for the treatment of substance use conditions: Evidence-based treatment practices. Washington, DC: National Quality Forum; 2007;
  38. Peirce JM, Petry NM, Stitzer MC, Blaine J, Kellogg S, Satterfield F, et al. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: A National Drug Abuse Treatment Clinical Trials Network Study. Archives of General Psychiatry. 2006;63:201–208
  39. Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JD, Cohen A, et al. Prize-based incentives increase retention in outpatient psychosocial treatment programs: Results of the National Drug Abuse Treatment Clinical Trials Network Study. Archives of General Psychiatry. 2005;62:1148–1156
  40. Rivara FP, Tollefson S, et al. Screening trauma patients for alcohol problems: Are insurance companies barriers?. Journal of Trauma-Injury Infection and Critical Care. 2000;48:115–118
  41. Roman PM, Ducharme LJ, Knudsen HK. Patterns of organization and management in private and pubic substance abuse treatment programs. Journal of Substance Abuse Treatment. 2006;31:235–243
  42. Schmidt L, Greenfield T, Mulia N. Unequal treatment: Racial and ethnic disparities in alcoholism treatment services. Alcohol Research and Health. 2006;29:49–54
  43. Schmidt L, Tam T, Larson MJ. Understanding the substance abuse treatment gap. Washington, DC: Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration; 2007;
  44. Stephenson J. Former addicts face barriers to treatment for HCV (hepatitis C virus). Journal of the American Medical Association. 2001;285:1003
  45. Sturm R, Pacula RL. State mental health parity laws: Cause or consequence of differences in use?. Health Affairs. 1999;18:182–192
  46. Substance Abuse and Mental Health Services Administration . National Survey of Substance Abuse Treatment Services (N-SSATS): 2006. Data on substance abuse treatment facilities. (DASIS Series: S-39, DHHS Publication No. (SMA) 07-4296). Rockville, MD: Substance Abuse and Mental Health Services Administration; 2007;
  47. Substance Abuse and Mental Health Services Administration . Results from the 2006 National Survey on Drug Use and Health: National findings. (NSDUH Series H-32, DHHS Publication No. SMA 07-4293 ed.). Rockville, MD: Substance Abuse and Mental Health Services Administration; 2007;
  48. Werner RM, Bradlow ET. Relationship between Medicare's hospital compare performance measures and mortality rates. Journal of the American Medical Association. 2006;296:2694–2702

PII: S0740-5472(10)00097-8

doi: 10.1016/j.jsat.2010.05.003

Journal of Substance Abuse Treatment
Volume 39, Issue 2 , Pages 87-95 , September 2010

Article Tools